Laxative Drug Products for Over-the-counter Human Use. Food and Drug Administration, HHS. Final Rule
Overview
Affiliations
The Food and Drug Administration (FDA) is issuing a final rule establishing that the over-the-counter (OTC) stimulant laxative ingredients danthron and phenolphthalein are not generally recognized as safe and effective and are misbranded. FDA is issuing this final rule as part of its ongoing review of OTC drug products after considering data and information on the safety of danthron and phenolphthalein.
Boudreau M, Hergenrother P RSC Med Chem. 2022; 13(6):711-725.
PMID: 35814932 PMC: 9215341. DOI: 10.1039/d2md00110a.
Al-Abri S, Olson K J Med Toxicol. 2013; 9(3):255-8.
PMID: 23591957 PMC: 3770998. DOI: 10.1007/s13181-013-0300-4.
Toxicology and carcinogenesis study of senna in C3B6.129F1-Trp53 tm1Brd N12 haploinsufficient mice.
Surh I, Brix A, French J, Collins B, Sanders J, Vallant M Toxicol Pathol. 2012; 41(5):770-8.
PMID: 23125117 PMC: 3672319. DOI: 10.1177/0192623312464304.